- Home
- BBGI vs SPRB Comparison
BBGI vs SPRB Comparison
Compare BBGI & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- SPRB
- Stock Information
- Founded
- BBGI 1961
- SPRB 2014
- Country
- BBGI United States
- SPRB United States
- Employees
- BBGI N/A
- SPRB N/A
- Industry
- BBGI Broadcasting
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- BBGI Consumer Discretionary
- SPRB Health Care
- Exchange
- BBGI Nasdaq
- SPRB Nasdaq
- Market Cap
- BBGI 13.2M
- SPRB 15.7M
- IPO Year
- BBGI 2000
- SPRB 2020
- Fundamental
- Price
- BBGI $8.27
- SPRB $0.36
- Analyst Decision
- BBGI
- SPRB Hold
- Analyst Count
- BBGI 0
- SPRB 7
- Target Price
- BBGI N/A
- SPRB $2.17
- AVG Volume (30 Days)
- BBGI 7.9K
- SPRB 595.7K
- Earning Date
- BBGI 02-10-2025
- SPRB 03-12-2025
- Dividend Yield
- BBGI N/A
- SPRB N/A
- EPS Growth
- BBGI N/A
- SPRB N/A
- EPS
- BBGI 1.69
- SPRB N/A
- Revenue
- BBGI $238,754,777.00
- SPRB $7,101,000.00
- Revenue This Year
- BBGI $2.55
- SPRB N/A
- Revenue Next Year
- BBGI N/A
- SPRB N/A
- P/E Ratio
- BBGI $4.90
- SPRB N/A
- Revenue Growth
- BBGI N/A
- SPRB N/A
- 52 Week Low
- BBGI $7.60
- SPRB $0.34
- 52 Week High
- BBGI $18.80
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- BBGI 41.01
- SPRB 37.97
- Support Level
- BBGI $8.20
- SPRB $0.34
- Resistance Level
- BBGI $9.46
- SPRB $0.39
- Average True Range (ATR)
- BBGI 0.43
- SPRB 0.03
- MACD
- BBGI -0.06
- SPRB 0.00
- Stochastic Oscillator
- BBGI 4.61
- SPRB 20.73
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).